⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9747313 | 1.00 | — | — | |
| SCHEMBL10123417 | 1.00 | — | — | |
| SCHEMBL9747668 | 1.00 | — | — | |
| SCHEMBL15177212 | 1.00 | — | — | |
| SCHEMBL11063180 | 1.00 | — | — | |
| SCHEMBL18398906 | 0.80 | LMNA (0.59) | — | |
| SCHEMBL7942964 | 0.80 | — | — | |
| SCHEMBL18398907 | 0.80 | LMNA (0.59) | — | |
| SCHEMBL9669465 | 0.80 | LMNA (0.59) | — | |
| SCHEMBL2711583 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605010-A1 | NUCLEIC ACID COMPLEXES AND USES THEREOF | BioNTech SE (DE) | 2025-08-27 | — | — | EP | claimed |
| WO-2024084462-A1 | NUCLEIC ACID COMPLEXES AND USES THEREOF | BioNTech SE (DE) | 2024-04-25 | — | — | WO | claimed |
| EP-1124797-B1 | N-ARYLSULFONYL AMINO ACID OMEGA AMIDES | AVENTIS PHARMA GMBH (DE) | 2004-03-03 | — | — | EP | claimed |
| EP-0576740-B1 | Process and device for the preparation of a contrast medium from a concentrate | SCHERING AG (DE) | 1998-07-29 | — | — | EP | claimed |
| EP-0794800-A1 | USE OF CHELATE COMPOUNDS AS DIAGNOSTIC AGENTS IN THE X-RAY EXAMINATION OF LIVER AND BILE DUCTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-09-17 | — | — | EP | claimed |
| EP-0399379-B1 | A lipase reagent system | MODROVICH IVAN ENDRE (US) | 1997-03-12 | — | — | EP | claimed |
| WO-1996016678-A1 | USE OF CHELATE COMPOUNDS AS DIAGNOSTIC AGENTS IN THE X-RAY EXAMINATION OF LIVER AND BILE DUCTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-06-06 | — | — | WO | claimed |
| EP-0400657-B1 | Process for developing of ps plates requiring no dampening water | FUJI PHOTO FILM CO LTD (JP) | 1996-03-27 | — | — | EP | claimed |
| US-4925652-A | NUCLEAR MAGNETIC RESONANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-05-15 | — | — | US | claimed |
| EP-0133674-B1 | NITROXYL COMPOUNDS, PROCESS FOR THEIR PREPARATION AND DIAGNOSTIC AGENTS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-09-20 | — | — | EP | claimed |
| US-4845090-A | NUCLEAR MAGNETIC RESONANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | claimed |
| US-4645667-A | CULTURING BIFIDOBACTERIUM | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1987-02-24 | — | — | US | claimed |
| EP-4743055-A1 | OXIDATIVE HAIR TREATMENT COMPOSITIONS COMPRISING POLYETHERS | Wella Germany GmbH (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4225479-B1 | FILTRATION MEMBRANE SYSTEMS, AND METHODS FOR PRODUCING PURIFIED WATER | ENTEGRIS INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12589074-B2 | Tablets having discontinuous coated regions | KENVUE BRANDS LLC (US) | 2026-03-31 | — | — | US | disclosed |
| US-20250369024-A1 | Acyloin Condensation Reactions, Enzymes, and Products Thereof | MOJIA BIOTECH PTE LTD (SG) | 2025-12-04 | — | — | US | disclosed |
| EP-0032387-A1 | Non ionic 5-C-substituted 2,4,6-triiodo-isophthalic acid derivatives, process for their preparation and X-ray contrast agents containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-07-22 | — | — | EP | disclosed |
| EP-0002450-B1 | 1-N-SUBSTITUTED-4,6-DI-O-(AMINOGLYCOSYL)-1,3-DIAMINO-CYCLITOL DERIVATIVES, PROCESS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THEM | BAYER AG (DE) | 1981-05-20 | — | — | EP | disclosed |
| US-4234572-A | AMINOGLYCOSIDE ANTIBIOTICS | BAYER AKTIENGESELLSCHAFT (DE) | 1980-11-18 | — | — | US | disclosed |
| EP-0002450-A1 | 1-N-substituted-4,6-di-O-(aminoglycosyl)-1,3-diamino-cyclitol derivatives, process for preparing them and medicaments containing them | BAYER AG (DE) | 1979-06-27 | — | — | EP | disclosed |